Lessons from China's Success in Achieving Malaria-Free Status

China's achievement in becoming malaria-free in 2021 serves as a vital blueprint for global efforts to combat and eliminate malaria. Experts highlight that this success was driven by a comprehensive national strategy encompassing long-term, adaptable interventions such as widespread use of bed nets, indoor spraying, targeted drug administration, and continuous surveillance. These measures evolved to address changing risk factors across regions like Hainan, Yunnan, and the Huai River Basin, demonstrating that persistent and flexible strategies can overcome challenges even in highly endemic areas.
However, experts also caution that complacency can lead to setbacks. The case of the Huai River Basin illustrates how early success in the 1980s led to reduced surveillance and funding, which sparked a resurgence of malaria in the early 2000s. Reintroduction of control measures was necessary to restore progress, emphasizing the importance of sustained vigilance.
Moreover, international cooperation, real-time data sharing, and innovative financing models—such as regional banks and partnerships—are crucial for maintaining elimination gains. The collection of studies underscores that long-term commitment, consistent funding, and data-driven strategies are essential for sustaining malaria control and preventing resurgence.
As global health initiatives face potential funding reductions, notably with declining support for the Global Fund and GAVI, there is an urgent need for continued investment. China's experience offers valuable insights, proving that elimination is achievable through dedicated effort and adaptive, long-term strategies. The authors stress that eliminating malaria requires unwavering persistence and innovation, especially as nations aim for a future where malaria is no longer a threat.
For more information, see the article: Mamadou Alpha Diallo et al, Learning from China's journey to achieve malaria elimination, BMJ (2025). [DOI: 10.1136/bmj.r758]
Source: https://medicalxpress.com/news/2025-04-china-malaria-free-status-crucial.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Updated Recommendations: COVID-19 Vaccines No Longer Suggested for Healthy Children and Pregnant Women
In 2025, health authorities announced that COVID-19 vaccines are no longer routinely recommended for healthy children and pregnant women, shifting focus to high-risk groups amid evolving evidence and regulatory changes.
Updated International Guidelines Highlight Mental and Heart Health Risks in Rare Skin Disorder
New international guidelines recommend screening for psychological and heart conditions in patients with the rare skin disorder X-linked ichthyosis, improving early detection and comprehensive care.
Impact of RSV Vaccines and Nirsevimab on Reducing Hospitalizations in Infants
Maternal RSV vaccines and nirsevimab significantly reduce hospitalization rates among infants during the 2024–2025 season, highlighting the importance of early prevention strategies.



